-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The net result for the period of deducting operating expenses from operating revenues.
-
Summary
-
Pure Bioscience, Inc. quarterly/annual Operating Income (Loss) history and growth rate from Q3 2010 to Q1 2025.
- Pure Bioscience, Inc. Operating Income (Loss) for the quarter ending April 30, 2025 was -$584K, a 28.5% increase year-over-year.
- Pure Bioscience, Inc. Operating Income (Loss) for the twelve months ending April 30, 2025 was -$2.64M, a 25.1% increase year-over-year.
- Pure Bioscience, Inc. annual Operating Income (Loss) for 2024 was -$3.19M, a 19.1% increase from 2023.
- Pure Bioscience, Inc. annual Operating Income (Loss) for 2023 was -$3.94M, a 5.88% decline from 2022.
- Pure Bioscience, Inc. annual Operating Income (Loss) for 2022 was -$3.72M, a 61.1% decline from 2021.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)